Catalyst Wire Dossier Catalyst Wire Dossier

NATACYN

NATAMYCIN · Harrow Eye, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NATACYN, covering 2008-07-18 to 2025-11-17. Get the full timeline:

Most recent: FDA Approved: NATACYN — Supplemental Application (Harrow Eye, LLC)

See pricing